118 related articles for article (PubMed ID: 32975490)
1. SOX2 Expression in Canine Neoplasia.
Miranda IC; Miller AD
Vet Pathol; 2021 Sep; 58(5):964-970. PubMed ID: 32975490
[TBL] [Abstract][Full Text] [Related]
2. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
3. SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer.
Lundberg IV; Edin S; Eklöf V; Öberg Å; Palmqvist R; Wikberg ML
BMC Cancer; 2016 Jul; 16():471. PubMed ID: 27411517
[TBL] [Abstract][Full Text] [Related]
4. SOX2 and Bcl-2 as a Novel Prognostic Value in Hepatocellular Carcinoma Progression.
Hosseini-Khah Z; Babaei MR; Tehrani M; Cucchiarini M; Madry H; Ajami A; Rakhshani N; Rafiei A; Nikbin B
Curr Oncol; 2021 Aug; 28(4):3015-3029. PubMed ID: 34436030
[TBL] [Abstract][Full Text] [Related]
5. Expression and clinical relevance of paired box protein 7 and sex determining region Y-box 2 in canine corticotroph pituitary adenomas.
van Rijn SJ; Pouwer MG; Tryfonidou MA; Grinwis GC; van der Bend JE; Beukers PE; Vastenhout N; Drouin J; Penning LC; Meij BP
Vet J; 2015 Jun; 204(3):315-21. PubMed ID: 25956343
[TBL] [Abstract][Full Text] [Related]
6. Sex determining region Y-box 2 (SOX2) amplification is an independent indicator of disease recurrence in sinonasal cancer.
Schröck A; Göke F; Wagner P; Bode M; Franzen A; Braun M; Huss S; Agaimy A; Ihrler S; Menon R; Kirsten R; Kristiansen G; Bootz F; Lengerke C; Perner S
PLoS One; 2013; 8(3):e59201. PubMed ID: 23544055
[TBL] [Abstract][Full Text] [Related]
7. Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma.
Sholl LM; Barletta JA; Yeap BY; Chirieac LR; Hornick JL
Am J Surg Pathol; 2010 Aug; 34(8):1193-8. PubMed ID: 20631605
[TBL] [Abstract][Full Text] [Related]
8. Assessment of SOX10 expression in 437 canine neoplasms of different embryologic origins.
Nelissen S; Miller AD
Vet Pathol; 2024 Feb; ():3009858241231562. PubMed ID: 38366813
[TBL] [Abstract][Full Text] [Related]
9. The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma.
Li J; Li Z; Wu Y; Wang Y; Wang D; Zhang W; Yuan H; Ye J; Song X; Yang J; Jiang H; Cheng J
Cell Death Dis; 2019 Aug; 10(8):603. PubMed ID: 31399556
[TBL] [Abstract][Full Text] [Related]
10. Low P16
Fu HC; Chuang IC; Yang YC; Chuang PC; Lin H; Ou YC; Chang Chien CC; Huang HS; Kang HY
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30150594
[TBL] [Abstract][Full Text] [Related]
11. SIX2 Mediates Late-Stage Metastasis via Direct Regulation of
Oliphant MUJ; Vincent MY; Galbraith MD; Pandey A; Zaberezhnyy V; Rudra P; Johnson KR; Costello JC; Ghosh D; DeGregori J; Espinosa JM; Ford HL
Cancer Res; 2019 Feb; 79(4):720-734. PubMed ID: 30606720
[TBL] [Abstract][Full Text] [Related]
12. Sox2-dependent inhibition of p21 is associated with poor prognosis of endometrial cancer.
Yamawaki K; Ishiguro T; Mori Y; Yoshihara K; Suda K; Tamura R; Yamaguchi M; Sekine M; Kashima K; Higuchi M; Fujii M; Okamoto K; Enomoto T
Cancer Sci; 2017 Apr; 108(4):632-640. PubMed ID: 28188685
[TBL] [Abstract][Full Text] [Related]
13. Expression of the embryonic transcription factor Oct4 in canine neoplasms: a potential marker for stem cell subpopulations in neoplasia.
Webster JD; Yuzbasiyan-Gurkan V; Trosko JE; Chang CC; Kiupel M
Vet Pathol; 2007 Nov; 44(6):893-900. PubMed ID: 18039902
[TBL] [Abstract][Full Text] [Related]
14. High expression of SOX2 is associated with poor prognosis in patients with salivary gland adenoid cystic carcinoma.
Dai W; Tan X; Sun C; Zhou Q
Int J Mol Sci; 2014 May; 15(5):8393-406. PubMed ID: 24828201
[TBL] [Abstract][Full Text] [Related]
15. The dark side of SOX2: cancer - a comprehensive overview.
Wuebben EL; Rizzino A
Oncotarget; 2017 Jul; 8(27):44917-44943. PubMed ID: 28388544
[TBL] [Abstract][Full Text] [Related]
16. Reprogramming of non-genomic estrogen signaling by the stemness factor SOX2 enhances the tumor-initiating capacity of breast cancer cells.
Vazquez-Martin A; Cufí S; López-Bonet E; Corominas-Faja B; Cuyàs E; Vellon L; Iglesias JM; Leis O; Martín AG; Menendez JA
Cell Cycle; 2013 Nov; 12(22):3471-7. PubMed ID: 24107627
[TBL] [Abstract][Full Text] [Related]
17. SOX2 regulates self-renewal and tumorigenicity of stem-like cells of head and neck squamous cell carcinoma.
Lee SH; Oh SY; Do SI; Lee HJ; Kang HJ; Rho YS; Bae WJ; Lim YC
Br J Cancer; 2014 Nov; 111(11):2122-30. PubMed ID: 25321191
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of SOX2 in vulvar intraepithelial neoplasia and squamous cell carcinoma.
Brustmann H; Brunner A
Int J Gynecol Pathol; 2013 May; 32(3):323-8. PubMed ID: 23518916
[TBL] [Abstract][Full Text] [Related]
19. Multiple pluripotent stem cell markers in human anaplastic thyroid cancer: the putative upstream role of SOX2.
Carina V; Zito G; Pizzolanti G; Richiusa P; Criscimanna A; Rodolico V; Tomasello L; Pitrone M; Arancio W; Giordano C
Thyroid; 2013 Jul; 23(7):829-37. PubMed ID: 23301671
[TBL] [Abstract][Full Text] [Related]
20. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
